COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE Trademark

Serial Number: 88909881 • Registration: 6317586

COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE is a trademark filed by American College of Rheumatology on May 11, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

American College of Rheumatology

2200 Lake Boulevard NE
Atlanta, GA 30319

Entity Type: 99

Legal Representation

Attorney of Record

Candice Reder

146 trademarks filed View all →

Correspondence Address

Candice Reder ICE MILLER LLP

Suite 2900

One American Square

Indianapolis, IN 46282

United States

Trademark Details

Filing Date

May 11, 2020

Registration Date

April 6, 2021

First Use Anywhere

March 12, 2020

First Use in Commerce

March 12, 2020

Goods & Services

Health care services, namely, data management and analysis services provided to the healthcare industry in the nature of providing a database in the field of COVID-19 health care treatment information and featuring reporting in the nature of inputting, analysis, and collection of data and information all for treatment and diagnostic purposes pertinent to improving the care of patients with rheumatic disease

Providing a website featuring technology that collects information by allowing users to access a registry collecting information pertinent to improving the care of patients with COVID-19 rheumatic disease

Maintaining a website registry of information pertinent to improving the care of patients with COVID-19 rheumatic disease; business services in the nature of data management and analysis services provided to the healthcare industry, namely, the collection, analysis, and reporting of healthcare quality data pertinent to improving the care of patients with COVID-19 rheumatic disease for business purposes